Bulking agents for urinary incontinence: Patient selection, counseling and technique

Expert Review of Obstetrics and Gynecology

Volumn 4, Issue 6, 2009, Pages 687-694

  Lightner, Deborah J ^a   Fox, Janelle A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Contigen ; Durasphere ; intrinsic sphincter deficiency; macroplastique; minimally invasive; stress urinary incontinence; urethral bulking agent

Indexed keywords

EID: 84867496686     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.09.38     Document Type: Article

References (70)

1. Nygaard IE, Thompson FL, Svengalis SL, Albright JP. Urinary incontinence in elite nulliparous athletes. Obstet. Gynecol. 84 (2), 183–187 (1994).
2. Raz S, Rodriguez LV. Female Urology (3rd Edition). Saunders Elsevier, Philadelphia, PA, USA (2008).
3. Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst. Rev. 18 (13), CD003881 (2007).
4. Cespedes RD, Serkin FB. Is injection therapy for stress urinary incontinence dead? No. Urology 73, 11–13 (2009).
5. Kong WG, Vasavada SP. Is injection therapy for stress urinary incontinence dead? Yes. Urology 73, 9–10 (2009).
6. Herschorn S, Radomski SB. Collagen injections for genuine stress urinary incontinence, patient selection and durability. Int. Urogynecol. J. Pelvic Floor Dysfunct. 8 (1), 18–24 (1997).
7. Bent AE, Foote JE, Siegel S, Faerber GJ, Choa R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J. Urol. 166 (4), 1354–1357 (2001).
8. ter Meulen PH, Berghmans LC, Nieman FH, van Kerrebroeck PE. Effects of macroplastique implantation system for stress urinary incontinence and urethral hypermobility in women. Int. Urogynecol. J. Pelvic Floor Dysfunct. 20, 177–183 (2009).
9. Khullar V, Cardozo LD, Abbott D, Anders K. GAX collagen in the treatment of urinary incontinence in elderly women, a two year follow up. Br. J. Obstet. Gynaecol. 104 (1), 96–99 (1997).
10. Winters JC, Chiverton A, Scarpero HM, Prats LJ Jr. Collagen injection therapy in elderly women, long-term results and patient satisfaction. Urology 55 (6), 856–861 (2000).
11. Kabalin JN. Treatment of post-prostatectomy stress urinary incontinence with periurethral polytetrafluoroethylene paste injection. J. Urol. 152 (5 Pt 1), 1463–1466 (1984).
12. Cummings JM, Boullier JA, Parra RO. Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence. J. Urol. 155 (3), 1011–1013 (1996).
13. Klutke JJ, Subir C, Andriole G, Klutke CG. Long-term results after antegrade collagen injection for stress urinary incontinence following radical retropubic prostatectomy. Urology 53 (5), 974–977 (1999).
14. Solomon LZ, Birch BR, Cooper AJ, Davies CL, Holmes SA. Nonhomologous bioinjectable materials in urology, ‘size matters’? BJU Int. 85 (6), 641–645. (2000).
15. Wilson S, Quek ML, Ginsberg DA. Transurethral injection of bulking agents for stress urinary incontinence following orthotopic neobladder reconstruction in women. J. Urol. 172 (1), 244–246 (2004).
16. Plotti F, Zullo MA, Sansone M et al. Post radical hysterectomy urinary incontinence, a prospective study of transurethral bulking agents injection. Gynecol. Oncol. 112 (1), 90–94 (2009).
17. Ben-Chaim J, Jeffs RD, Peppas DS, Gearhart JP. Submucosal bladder neck injections of glutaraldehyde cross-linked bovine collagen for the treatment of urinary incontinence in patients with the exstrophy/epispadias complex. J. Urol. 154 (2 Pt 2), 862–864 (1995).
18. Rosalia M, Anthony JC, Mark PC, Richard CR. Alternative use of dextranomer/hyaluronic acid copolymer, the efficacy of bladder neck injections for urinary incontinence. J. Urol. 174 (4), 1691–1694 (2005).
19. Burki T, Hamid R, Ransley PG, Mushtaq I, Duffy PG. Injectable polydimethylsiloxane for treating incontinence in children with the exstrophy–epispadias complex, long-term results. BJU Int. 98 (4), 849–853 (2006).
20. Nijhuis PH, van den Bogaard TE, Daemen MJ, Baeten CG. Perianal injection of polydimethylsiloxane (Bioplastique implants) paste in the treatment of soiling, pilot study in rats to determine migratory tendency and locoregional reaction. Dis. Colon Rectum 41 (5), 624–629 (1998).
21. Malouf AJ, Vaizey CJ, Norton CS, Kamm MA. Internal anal sphincter augmentation for fecal incontinence using injectable silicone biomaterial. Dis. Colon Rectum 44 (4), 595–600 (2001).
22. Davis K, Kumar D, Poloniecki J. Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence. Aliment Pharmacol. Ther. 18 (2), 237–243 (2003).
23. Stojkovic SG, Lim M, Burke D, Finan PJ, Sagar PM. Intra-anal collagen injection for the treatment of faecal incontinence. Br. J. Surg. 93 (12), 1514–1518. (2006).
24. McClelland M, Delustro F. Evaluation of antibody class in response to bovine collagen treatment in patients with urinary incontinence. J. Urol. 155 (6), 2068–2073 (1996).
25. Heit M. Prolonged urinary retention after collagen periurethral injections, a sequela of humoral immunity. Obstet. Gynecol. 90 (4), 693–695 (1997).
26. Lightner D, Calvosa C, Andersen R et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58 (1), 12–15 (2001).
27. Mayer RD, Dmochowski RR, Appell RA et al. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology 69 (5), 876–880 (2007).
28. Henly DR, Barrett DM, Weiland TL, O’Connor MK, Malizia AA, Wein AJ. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J. Urol. 153 (6), 2039–2043 (1995).
29. Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J. Urol. 181 (1), 204–210 (2009).
30. Petrou SP, Lisson SW, Crook JE, Lightner DJ. An exploration into patient preference for injectable therapy over surgery in the treatment of female urinary incontinence. Int. Braz. J. Urol. (2006).
31. McCrery RJ, Appell RA. Safety of carbon bead injection for incontinence in patients taking warfarin. Urology 67 (1), 97–99 (2006).
32. Sweat SD, Lightner DJ. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J. Urol. 161 (1), 93–96 (1999).
33. Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence, a randomized double-blind controlled trial. J. Urol. 165 (1), 153–158 (2001).
34. Malizia AA Jr, Reiman HM, Myers RP et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251 (24), 3277–3281 (1984).
35. Erekson EA, Sung VW, Rardin CR, Myers DL. Ethylene vinyl alcohol copolymer erosions after use as a urethral bulking agent. Obstet. Gynecol. 109 (2 Pt 2), 490–492 (2007).
36. Hurtado EA, McCrery RJ, Appell RA. Complications of ethylene vinyl alcohol copolymer as an intraurethral bulking agent in men with stress urinary incontinence. Urology 71 (4), 662–665 (2008).
37. Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18 (8), 869–873 (2007).
38. Stothers L, Goldenberg SL, Leone EF. Complications of periurethral collagen injection for stress urinary incontinence. J. Urol. 159 (3), 806–807 (1998).
39. McKinney CD, Gaffey MJ, Gillenwater JY. Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J. Urol. 153 (1), 149–151 (1995).
40. Hartanto VH, Lightner DJ, Nitti VW. Endoscopic evacuation of Durasphere. Urology 62 (1), 135–137 (2003).
41. Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19 (9), 1315–1317 (2008).
42. Ko EY, Williams BF, Petrou SP. Bulking agent induced early urethral prolapse after distal urethrectomy. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18 (12), 1511–1513 (2007).
43. Harris RL, Cundiff GW, Coates KW, Addison WA, Bump RC. Urethral prolapse after collagen injection. Am. J. Obstet. Gynecol. 178 (3), 614–615 (1998).
44. Ghoniem GM, Khater U. Urethral prolapse after durasphere injection. Int. Urogynecol. J. Pelvic Floor Dysfunct. 17 (3), 297–298 (2006).
45. Alkan M, Talim B, Ciftci AO, Senocak ME, Caglar M, Buyukpamukcu N. Histological response to injected gluteraldehyde cross-linked bovine collagen based implant in a rat model. BMC Urol. 6, 3 (2006).
46. Frey P, Berger D, Jenny P, Herzog B. Subureteral collagen injection for the endoscopic treatment of vesicoureteral reflux in children. Follow up study of 97 treated ureters and histological analysis of collagen implants. J. Urol. 148 (2), 718–723 (1992).
47. Leonard MP, Canning DA, Epstein JI, Gearhart JP, Jeffs RD. Local tissue reaction to the subureteral injection of glutaraldehyde cross-linked bovine collagen in humans. J. Urol. 143 (6), 1209–1212 (1990).
48. Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J. Am. Acad. Derm. 25, 319–326 (1991).
49. McLennan MT, Bent AE. Suburethral abscess, a complication of periurethral collagen injection therapy. Obstet. Gynecol. 92 (4), 650–652 (1998).
50. Palma PC, Riccetto CL, Netto NR Jr. Urethral pseudolipoma, a complication of periurethral lipo-injection for stress urinary incontinence in a woman. J. Urol. 155 (2), 646 (1996).
51. Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J. Urol. 175 (4), 1408–1410 (2006).
52. Abdelwahab HA, Ghoniem GM. Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18 (11), 1379–1380 (2007).
53. Stenberg AM, Sundin A, Larsson BS, Lackgren G, Stenberg A. Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J. Urol. 158 (5), 1937–1941 (1997).
54. Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ. Carbon coated zirconium beads in β-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency, continence and satisfaction after extended followup. J. Urol. 171 (3), 1152–1155 (2004).
55. Zullo MA, Plotti F, Bellati F, Muzii L, Angioli R, Panici PB. Transurethral polydimethylsiloxane implantation: a valid option for the treatment of stress urinary incontinence due to intrinsic sphincter deficiency without urethral hypermobility. J. Urol. 171 (3), 1152–1155 (2005).
56. Leach GE, Dmochowski RR, Appell RA et al. Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J. Urol. 158 (3), 875–880 (1997).
57. Lightner DJ. Review of the available urethral bulking agents. Curr. Opin. Urol. 12 (4), 333–338 (2002).
58. Chapple CR, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A, Sultan AH. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur. Urol. 48 (3), 488–494 (2005).
59. Bridges MD, Petrou SP, Lightner DJ. Urethral bulking agents: imaging review. AJR Am. J. Roentgenol. 185, 257–264 (2005).
60. Poon CI, Zimmern PE. Role of three-dimensional ultrasound in assessment of women undergoing urethral bulking agent therapy. Curr. Opin. Obstet. Gynecol. 16 (5), 411–417 (2004).
61. Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann. Intern. Med. 148 (6), 459–473 (2008).
62. Sirls LT, Foote JE, Kaufman JM et al. Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 13 (2), 88–95 (2002).
63. El-Shafey el-SI. Complications from repeated injection or puncture of old polyacrylamide gel implant sites, case reports. Aesthetic Plast. Surg. 32 (1), 162–165 (2008).
64. Balmforth J, Cardozo LD. Trends toward less invasive treatment of female stress urinary incontinence. Urology 62 (4 Suppl. 1), 52–60 (2003).
65. ® Collagen Implant. Product specifications, technical tips, FAQ (2009) www.bardurological.com (Accessed 25 March 2009)
66. Durasphere EXP www.carbonmed.com/about.htm (Accessed March 2009)
67. Preparation and use of the macroplastique system (2007) www.uroplasty.com/Uroplasty/view/files/pdf/0550005.pdf (Accessed 25 March 2009)
68. ®. Bulkamid product information (2008) www.bulkamid.com (Accessed 18 March 2009)
69. ®): A Female Stress Urinary Incontinence Device www.uromedica-inc.com/ous/act
70. ® AttenueX Intravesical System (2007) www.solacetx.com